Order byBest matchMost fresh

Covid-19, FDA

Digest more
Top News
Overview
Impacts
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.

Continue reading

Infectious Disease Advisor · 28m
FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
FDA panel recommends keeping COVID shots targeted to same strain as last year
Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to target their shots to the so-called JN.1 coronavirus strain for the upcoming fall and winter seasons, ...

Continue reading

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules
wtvr · 16h
FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals
US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026
Public health experts say that there is no certainty on which strains are going to be dominant.

Continue reading

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?
FDA panel debates COVID vaccine recipe as questions swirl about fall shots
BioSpace1h
FDA Vaccine Advisors Agree on COVID-19 Vaccine as New Framework Looms as ‘Elephant in the Room’
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
The FDA may restrict COVID shots. Who will be able to get them?
The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many Americans ineligible. Here's what we know.
NewsX1h
Covid-19 Booster Rules To Change? Fda Questions Yearly Shots For Healthy People Amid India Spike
The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, India reports fresh cases, with Kerala on alert.
With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
Feedback